4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001944119-26-000031
CHIEF FINANCIAL OFFICER sold 3,729 shares at an average $60.77 ($226,597)
- CHIEF FINANCIAL OFFICER acquired 7,197 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Feeley Kevin · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-16 | Exercise or conversion : show line 1 in the form | +7,197 | 43,683 | D | ||
| 2026-06-16 | Sale : show line 2 in the form | −760 | $59.75 | $45,413 | 42,923 | D |
| 2026-06-16 | Sale : show line 3 in the form | −2,106 | $60.83 | $128,106 | 40,817 | D |
| 2026-06-16 | Sale : show line 4 in the form | −863 | $61.50 | $53,078 | 39,954 | D |
| Open-market sales · 3,729 sh · avg $60.77 · $226,597 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-16 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −7,197 | 21,590 | D |
Loading xslF345X06/form4-06182026_080621.xml…